Comparison Between Hyperbaric Bupivacaine With Fentanyl vs. Hyperbaric Bupivacaine With Dexmedetomidine in Reducing Visceral Pain During Cesarean Delivery Under Spinal Anaesthesia

Launched by TRIBHUVAN UNIVERSITY TEACHING HOSPITAL, INSTITUTE OF MEDICINE. · Apr 11, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to compare two different pain relief methods for women undergoing a planned cesarean delivery. Specifically, it will look at whether using a combination of a common local anesthetic called bupivacaine with fentanyl or with dexmedetomidine is more effective at reducing visceral pain, which can feel like discomfort or heaviness in the abdomen during surgery. The goal is to help doctors understand which option may provide better pain control for patients during this process.

To be eligible for this trial, participants must be women aged 18 years or older who are having an elective cesarean section and are in good health (classified as ASA PS II). They should be at least 37 weeks pregnant and have a height of 150 cm or more. Women who have certain medical conditions, allergies to the medications involved, or communication difficulties will not be able to participate. If you join the study, you can expect to provide feedback on your pain levels during surgery, which will help researchers determine the best approach to manage pain in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Elective caesarean deliveries under SAB
• • ASA PS II
• • Age ≥18 years
• • Term pregnancy ≥37 weeks of gestation
• • Height ≥ 150
• Exclusion Criteria:
• • Patients with medical disorder in pregnancy (neurological, psychiatric, cardiopulmonary,
• • hepatorenal diseases, coagulopathy)
• • Patient refusal to participate
• • Allergy or hypersensitivity to LA, fentanyl or dexmedetomidine
• • Patients with communication problem
• • Patient with bradycardia (HR- less than 60)